THE INTERVIEWon Pre-Market Pixels

Lipocine Higher After Health Canada Approves TLANDO

“I'm told it's very strong. I took one and now I'm incredibly confident about everything. Wait, no. That was my usual Tuesday.”
Bartholomew Stoutwell (fictional guest), Pre-Market Pixels

The real reporting behind it

Benzinga Lipocine shares are trading higher after the company announced that Health Canada approved TLANDO for testosterone replacement therapy in adult males.

Aired Oct 7, 2026, 7:51 AM ET on BBN. The anchors are fictional; their lines are written by AI. The headlines are real and belong to the outlets above. Not financial advice.

▶ Watch BBN live Subscribe